ISSN 2639-9431
Vol. 1, Issue 1, 2018April 25, 2018 EDT
Immunocompatibility of Rad-PC-Rad liposomes in vitro, based on human complement activation and cytokine release
Immunocompatibility of Rad-PC-Rad liposomes in vitro, based on human complement activation and cytokine release
Bert Müller, Sofiya Matviykiv, Gabriela Gerganova, Tamás Mészáros, Gergely Tibor Kozma, Ute Mettal, Frederik Neuhaus, Takashi Ishikawa, János Szebeni, Andreas Zumbuehl,
Articles in Vol. 1, Issue 1, 2018
Vol. 1, Issue 1, 2018
- A porcine model of complement activation-related pseudoallergy to nano-pharmaceuticals: Pros and cons of translation to a preclinical safety testJános SzebeniRudolf UrbanicsLászló DézsiPéter Bedőcs
- Origins to Outcomes: A Role for Extracellular Vesicles in Precision MedicineAdriele Prina-MelloCiaran Magus MaguireJohn Savage
- Discrepancies in the in vitro and in vivo role of scavenger receptors in clearance of nanoparticles by Kupffer cellsDmitri SimbergErnest GromanGuankui Wang
- Immunocompatibility of Rad-PC-Rad liposomes in vitro, based on human complement activation and cytokine releaseBert MüllerSofiya MatviykivGabriela GerganovaTamás MészárosGergely Tibor KozmaUte MettalFrederik NeuhausTakashi IshikawaJános SzebeniAndreas Zumbuehl
- Improving Innovation in Nano-Healthcare FundingMike Eaton
- Balancing Interests of Science, Scientists, and the Publishing BusinessLajos P Balogh
- The Story of Precision Nanomedicine – the JournalLajos Balogh
Müller, Bert, Sofiya Matviykiv, Gabriela Gerganova, Tamás Mészáros, Gergely Tibor Kozma, Ute Mettal, Frederik Neuhaus, Takashi Ishikawa, János Szebeni, and Andreas Zumbuehl. 2018. “Immunocompatibility of Rad-PC-Rad Liposomes in Vitro, Based on Human Complement Activation and Cytokine Release.” Precision Nanomedicine 1 (1): 43–62. https://doi.org/10.29016/180419.2.